Glial Dysfunction in Abstinent Methamphetamine Abusers

[1]  R. LaLumiere,et al.  Glutamate transmission in addiction , 2009, Neuropharmacology.

[2]  O. Abulseoud,et al.  Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults. , 2009, Radiology.

[3]  Sang-Woo Lee,et al.  Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers. , 2009, Journal of psychiatric research.

[4]  B. Ross,et al.  Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe. , 2008, Journal of magnetic resonance.

[5]  B. Ross,et al.  MR spectroscopy in diagnosis and neurological decision-making. , 2008, Seminars in neurology.

[6]  M. Buonocore,et al.  Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers , 2007, Biological Psychiatry.

[7]  P. Renshaw,et al.  Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. , 2007, Drug and Alcohol Dependence.

[8]  Shizhe Li,et al.  Novel strategy for cerebral 13C MRS using very low RF power for proton decoupling , 2007, Magnetic resonance in medicine.

[9]  Kiralee M. Hayashi,et al.  Cerebral Metabolic Dysfunction and Impaired Vigilance in Recently Abstinent Methamphetamine Abusers , 2005, Biological Psychiatry.

[10]  George V Rebec,et al.  Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. , 2005, Journal of the experimental analysis of behavior.

[11]  P. Sundgren,et al.  Magnetic resonance spectroscopy. , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[12]  P. Renshaw,et al.  Frontal Glucose Hypometabolism in Abstinent Methamphetamine Users , 2005, Neuropsychopharmacology.

[13]  M. Buonocore,et al.  Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. , 2005, Archives of general psychiatry.

[14]  N. Volkow,et al.  Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. , 2004, The American journal of psychiatry.

[15]  Fahmeed Hyder,et al.  In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. , 2003, Annual review of physiology.

[16]  S. Cerdán.  13C NMR and cerebral biochemistry , 2003, NMR in biomedicine.

[17]  Kent Harris,et al.  Clinical experience with 13C MRS in vivo , 2003, NMR in biomedicine.

[18]  F. Shic,et al.  Automated data processing of [1H-decoupled] 13C MR spectra acquired from human brain in vivo. , 2003, Journal of magnetic resonance.

[19]  F. Shic,et al.  Reduced glutamate neurotransmission in patients with Alzheimer's disease–an in vivo 13C magnetic resonance spectroscopy study , 2003, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  Adolf Pfefferbaum,et al.  Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study , 2002, Psychiatry Research: Neuroimaging.

[21]  Rita Z. Goldstein,et al.  Role of Dopamine, the Frontal Cortex and Memory Circuits in Drug Addiction: Insight from Imaging Studies , 2002, Neurobiology of Learning and Memory.

[22]  Jun Shen,et al.  Magnetic resonance spectroscopic approaches to studying neuronal: glial interactions , 2002, Biological Psychiatry.

[23]  M. Iyo,et al.  Metabolite Alterations in Basal Ganglia Associated with Methamphetamine-related Psychiatric Symptoms: A Proton MRS Study , 2002, Neuropsychopharmacology.

[24]  K. Petersen,et al.  Astroglial Contribution to Brain Energy Metabolism in Humans Revealed by 13C Nuclear Magnetic Resonance Spectroscopy: Elucidation of the Dominant Pathway for Neurotransmitter Glutamate Repletion and Measurement of Astrocytic Oxidative Metabolism , 2002, The Journal of Neuroscience.

[25]  S. Bluml,et al.  Tricarboxylic acid cycle of glia in the in vivo human brain , 2002, NMR in biomedicine.

[26]  N. Volkow,et al.  Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence , 2001, The Journal of Neuroscience.

[27]  Angel Moreno,et al.  Alternative 1‐13C glucose infusion protocols for clinical 13C MRS examinations of the brain , 2001, Magnetic resonance in medicine.

[28]  B. Ross,et al.  [1‐13C] glucose MRS in chronic hepatic encephalopathy in man , 2001, Magnetic resonance in medicine.

[29]  Linda Chang,et al.  Evidence for long-term neurotoxicity associated with methamphetamine abuse , 2000, Neurology.

[30]  M. Ernst,et al.  Orbitofrontal cortex and human drug abuse: functional imaging. , 2000, Cerebral cortex.

[31]  Jullie W Pan,et al.  Measurement of the Tricarboxylic Acid Cycle Rate in Human Grey and White Matter in Vivo by 1H-[13C] Magnetic Resonance Spectroscopy at 4.1T , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  R. Shulman,et al.  Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Bluml,et al.  Proton‐Decoupled 31P Magnetic Resonance Spectroscopy Reveals Osmotic and Metabolic Disturbances in Human Hepatic Encephalopathy , 1998, Journal of neurochemistry.

[34]  H. Bachelard.  Landmarks in the Application of 13C-Magnetic Resonance Spectroscopy to Studies of Neuronal/Glial Relationships , 1998, Developmental Neuroscience.

[35]  R. A. Waniewski,et al.  Preferential Utilization of Acetate by Astrocytes Is Attributable to Transport , 1998, The Journal of Neuroscience.

[36]  R. Gruetter,et al.  Simultaneous Determination of the Rates of the TCA Cycle, Glucose Utilization, α-Ketoglutarate/Glutamate Exchange, and Glutamine Synthesis in Human Brain by NMR , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  B. Yamamoto,et al.  Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux , 1994, Synapse.

[38]  B. Künnecke,et al.  Cerebral metabolism of [1,2-13C2]acetate as detected by in vivo and in vitro 13C NMR. , 1990, The Journal of biological chemistry.

[39]  D. Muir,et al.  Acetate and fluoroacetate as possible markers for glial metabolism in vivo , 1986, Brain Research.

[40]  B. Siesjö.  The relation between the bicarbonate concentration in blood plasma and in brain tissue , 1964, Experientia.

[41]  M. Olive,et al.  Glutamatergic substrates of drug addiction and alcoholism. , 2008, Biochemical pharmacology.

[42]  B. Schweinsburg,et al.  Clinical experience with 13 C MRS in vivo , 2003 .

[43]  B. Künnecke,et al.  Adult-onset hypothyroidism and the cerebral metabolism of (1,2-13C2) acetate as detected by 13C nuclear magnetic resonance. , 1995, Endocrinology.

[44]  H. Pincus,et al.  DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders. , 1994, Hospital & community psychiatry.

[45]  C. Robertson,et al.  Cerebral metabolism. , 1994, Neurosurgery clinics of North America.

[46]  R G Shulman,et al.  Non-invasive measurements of the cerebral steady-state glucose concentration and transport in humans by 13C nuclear magnetic resonance. , 1993, Advances in experimental medicine and biology.

[47]  S. Cerdán,et al.  NMR studies of metabolism. , 1990, Annual review of biophysics and biophysical chemistry.

[48]  P B Corr,et al.  Automated data processing. An essential decision-making aid in the treatment of acute myocardial infarction. , 1977, Advances in cardiology.

[49]  T. Todisco,et al.  [Calculation of plasma bicarbonates using Henderson-Hasselbalch equation. Influence of pK changes as a function of pH]. , 1973, Minerva nefrologica.